Comparison · NCT06029673-325fcda8
Cabergoline vs Placebo: Number of Participants Reporting Significant Bother From Breast Pain
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Cabergoline vs Placebo: Number of Participants Reporting Significant Bother From Breast Pain. Trial comparisons, record NCT06029673-325fcda8. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT06029673-325fcda8
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0313 | 0.00554 | 0.157 | wilson | |
| Risk in group 2 | 0.206 | 0.103 | 0.368 | wilson | |
| Risk difference, group 1 minus group 2 | -0.175 | -0.339 | -0.0121 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.152 | 0.0198 | 1.17 | log | |
| Odds ratio, group 1 over group 2 | 0.124 | 0.0144 | 1.08 | log | |
| Number needed to treat, for one fewer participant with the outcome on Cabergoline than on Placebo | 5.73 | 2.95 | 82.5 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Cabergoline | After the completion of the surgical procedure or medical induction for the early second-trimester abortion or fetal loss, the participant is administered cabergoline 1mg orally with juice or water by the clinician or study investigator. | 1 | 32 | OG000 |
| Group 2 | Placebo | After the completion of the surgical procedure or medical induction for the early second-trimester abortion or fetal loss, the participant is administered a placebo pill orally with juice or water by the clinician or study investigator. | 7 | 34 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants Reporting Significant Bother From Breast Pain
- Description
- Assessed using a Facial Pain Score; scale range 0-6 (higher scores indicate greater pain), with significant bother \>=4
- Time frame
- Day 4 after procedure
- Population
- ITT analysis - participants that did not provide any additional surveys beyond date of enrollment were excluded
Source ClinicalTrials.gov
Trial
- Title
- Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss
- NCT number
- NCT06029673
- Phases
- PHASE2
- Conditions
- Lactation Suppressed
- Interventions
- Cabergoline 1 MG, Placebo
- Lead sponsor
- Stanford University
- Results first posted
- 2025-10-03
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT06029673?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT06029673-325fcda8